Lv1
10 积分 2025-12-24 加入
Progress in the treatment of malignant ascites
3小时前
待确认
CLDN18.2 chimeric antigen receptor T cell therapy for patients with advanced gastric and pancreatic adenocarcinoma: Results of ELIMYN18.2 phase 1b clinical trial
3小时前
已完结
Effectiveness and safety of ruxolitinib cream in Chinese patients with nonsegmental vitiligo
7个月前
已完结
皖公网安备34019202002308
